SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001445546-16-006494
Filing Date
2016-01-27
Accepted
2016-01-27 09:49:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g_3.txt SC 13G 12701
2 JOINT FILING AGREEMENT ex99_3.txt EX-99.1 2244
  Complete submission text file 0001445546-16-006494.txt   16647
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 161363176
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 12O EAST LIBERTY DRIVE SUITE 400 WHEATON IL 60187
Business Address 12O EAST LIBERTY DRIVE SUITE 400 WHEATON IL 60187 630-765-8000
FIRST TRUST PORTFOLIOS LP (Filed by) CIK: 0001184765 (see all company filings)

IRS No.: 000000000 | State of Incorp.: IL
Type: SC 13G